Derakhshandeh N, Nazifi S, Mogheiseh A, Divar M, Dadvand Z, Karimizadeh M
BMC Vet Res. 2025; 21(1):142.
PMID: 40038732
PMC: 11881314.
DOI: 10.1186/s12917-025-04597-z.
Chi H, Ma L, Zeng F, Wang X, Peng P, Bai X
Invest Ophthalmol Vis Sci. 2025; 66(2):15.
PMID: 39913165
PMC: 11806429.
DOI: 10.1167/iovs.66.2.15.
Li K, Tolman N, V Segre A, Stuart K, Stuart K, Zeleznik O
bioRxiv. 2025; .
PMID: 39896457
PMC: 11785086.
DOI: 10.1101/2025.01.18.633745.
La Rosa L, Pepe V, Lazzara F, Romano G, Conti F, Giuffrida E
Pharmaceutics. 2025; 17(1.
PMID: 39861721
PMC: 11769253.
DOI: 10.3390/pharmaceutics17010073.
Obeng E, Shen B, Wang W, Xie Z, Zhang W, Li Z
Regen Biomater. 2025; 12:rbae133.
PMID: 39776856
PMC: 11703557.
DOI: 10.1093/rb/rbae133.
A Reduction in Mitophagy Is Associated with Glaucomatous Neurodegeneration in Rodent Models of Glaucoma.
Chaphalkar R, Kodati B, Maddineni P, He S, Brooks C, Stankowska D
Int J Mol Sci. 2024; 25(23).
PMID: 39684751
PMC: 11642561.
DOI: 10.3390/ijms252313040.
Decoding senescence of aging single cells at the nexus of biomaterials, microfluidics, and spatial omics.
Venkataraman A, Kordic I, Li J, Zhang N, Bharadwaj N, Fang Z
NPJ Aging. 2024; 10(1):57.
PMID: 39592596
PMC: 11599402.
DOI: 10.1038/s41514-024-00178-w.
Systematic Review and Meta-Analysis on the Association Between Daily Niacin Intake and Glaucoma.
Nicola C, Marinescu M, Firan A, Naidin M, Ciuluvica R, Rosu M
Nutrients. 2024; 16(21).
PMID: 39519437
PMC: 11547537.
DOI: 10.3390/nu16213604.
Glaucoma and dietary links: insights from high-salt intake, the Mediterranean diet, and specific nutrients.
Yang Y, Zhou H, Hong Z
Front Nutr. 2024; 11:1461748.
PMID: 39512517
PMC: 11541052.
DOI: 10.3389/fnut.2024.1461748.
Massively parallel sequencing of mitochondrial genome in primary open angle glaucoma identifies somatically acquired mitochondrial mutations in ocular tissue.
Vallabh N, Lane B, Simpson D, Fuchs M, Choudhary A, Criddle D
Sci Rep. 2024; 14(1):26324.
PMID: 39487142
PMC: 11530638.
DOI: 10.1038/s41598-024-72684-6.
Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies.
Wang L, Huang C, Lin I
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458902
PMC: 11510571.
DOI: 10.3390/ph17101261.
Gene therapy for glaucoma: Targeting key mechanisms.
Henderson J, OCallaghan J, Campbell M
Vision Res. 2024; 225:108502.
PMID: 39423611
PMC: 11579448.
DOI: 10.1016/j.visres.2024.108502.
Translational Research and Therapies for Neuroprotection and Regeneration of the Optic Nerve and Retina: A Narrative Review.
Oshitari T
Int J Mol Sci. 2024; 25(19).
PMID: 39408817
PMC: 11476551.
DOI: 10.3390/ijms251910485.
Uncovering the impact and mechanisms of air pollution on eye and ear health in China.
Fang J, Yu Y, Zhang G, Zhu P, Shi X, Zhang N
iScience. 2024; 27(9):110697.
PMID: 39262800
PMC: 11387599.
DOI: 10.1016/j.isci.2024.110697.
Differential protection by nicotinamide in a mouse model of glaucoma DBA/2J revealed by second-harmonic generation microscopy.
Boodram V, Lim H
PLoS One. 2024; 19(9):e0309400.
PMID: 39255314
PMC: 11386466.
DOI: 10.1371/journal.pone.0309400.
The effects of light emitting diodes on mitochondrial function and cellular viability of M-1 cell and mouse CD1 brain cortex neurons.
Lee J, Park H, Kang S, Lee S, Lee C
PLoS One. 2024; 19(8):e0306656.
PMID: 39213294
PMC: 11364243.
DOI: 10.1371/journal.pone.0306656.
NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review.
Gemae M, Bassi M, Wang P, Chin E, Almeida D
Nutrients. 2024; 16(16).
PMID: 39203931
PMC: 11357639.
DOI: 10.3390/nu16162795.
AAV-NDI1 Therapy Provides Significant Benefit to Murine and Cellular Models of Glaucoma.
Millington-Ward S, Palfi A, Shortall C, Finnegan L, Bargroff E, Post I
Int J Mol Sci. 2024; 25(16).
PMID: 39201561
PMC: 11354491.
DOI: 10.3390/ijms25168876.
Nicotinamide: Bright Potential in Glaucoma Management.
Babighian S, Gattazzo I, Zanella M, Galan A, DEsposito F, Musa M
Biomedicines. 2024; 12(8).
PMID: 39200120
PMC: 11352092.
DOI: 10.3390/biomedicines12081655.
Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma.
Cimaglia G, Tribble J, Votruba M, Williams P, Morgan J
Acta Neuropathol Commun. 2024; 12(1):137.
PMID: 39180087
PMC: 11342512.
DOI: 10.1186/s40478-024-01850-8.